NurExone Biologic Inc. (TSXV:NRX)

Canada flag Canada · Delayed Price · Currency is CAD
0.6800
0.00 (0.00%)
May 23, 2025, 4:00 PM EDT
38.78%
Market Cap 50.71M
Revenue (ttm) n/a
Net Income (ttm) -8.34M
Shares Out 78.01M
EPS (ttm) -0.12
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 19,426
Average Volume 17,471
Open 0.6800
Previous Close 0.6800
Day's Range 0.6700 - 0.6800
52-Week Range 0.4600 - 0.8700
Beta 0.02
RSI 39.38
Earnings Date May 27, 2025

About NurExone Biologic

NurExone Biologic Inc., operates as a pharmaceutical technology company. It is developing and commercializing the ExoTherapy platform for production of exosome-loaded nanodrugs. The company is also developing an off-the-shelf, non-invasive, and novel treatment for the reversal or reduction of paralysis following spinal cord injury using membrane-bound extracellular vesicles technology, as well as to treat brain trauma injury, and other brain and neurological indications. Its technology includes ExoPTEN, for acute spinal cord injury, and glaucom... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2020
Country Canada
Stock Exchange TSX Venture Exchange
Ticker Symbol NRX
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.